Zelda Therapeutics Ltd (ASX: ZLD, OTCQB: ZLDAF, Zelda): has expanded its human clinical trial program in a clinical trial partnership with the prestigious St Vincent’s Hospital in Melbourne to examine the potential to use certain cannabinoid medications in patients on chronic, high dose opioid pain management therapy.

ASX Announcement: Zelda Partners St Vincent’s Hospital on Opioid Reduction Study